General Information of the Compound
| Compound ID |
CP0474718
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(4-fluorophenyl)-5-[[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]methyl]-4,5-dihydro-1,2-oxazole
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H27FN4O
|
||||||||||||||||||
| Molecular Weight |
406.505
|
||||||||||||||||||
| Canonical SMILES |
CN1CCN2[C@H]3CCN(CC4CC(=NO4)c4ccc(F)cc4)C[C@H]3c3cccc1c23
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H27FN4O/c1-27-11-12-29-22-9-10-28(15-20(22)19-3-2-4-23(27)24(19)29)14-18-13-21(26-30-18)16-5-7-17(25)8-6-16/h2-8,18,20,22H,9-15H2,1H3/t18?,20-,22-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PBQSDWFDAXRGLF-KAOUJKNGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C